302
[7] Sezai, A., Shiono, M., Hata, M., Lida, M., Yoda, M., Wakui, S., et al. (2006). Years experience in mitral
valve replacement using Starr-Edwards, St. Jude Medical and ATS valves.
Ann Thorac Cardiovasc
Surg
. 12(4), 249-56.
[8] Hanania, G., Maroni, J.P., Hajj, Y.E. (2003). Anticoagulation of valvular prostheses.
Ann Cardiol
Angeiol (Paris)
. 52(5), 290-6.
[9] Kaneko, T. and Aranki, S.F. (2013). Anticoagulation for prosthetic valves.
Thrombosis
. 2013, 1-4.
[10] Jacobs, L.G. (2008). Warfarin Pharmacology, Clinical Management, and Evaluation of Hemorrhagic
Risk for the Elderly.
Cardiology Clinics
. 26(2), 157-67.
[11] Ageno, W., Gallus, A.S., Wittkowsky, A., Crowther, M., Hylek, E.M., et al. (2012). Oral Anticoagulant
Therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest
Physicians Evidence-Based Clinical Practice Guidelines.
Chest
. 141(2)(suppl), e44s-e88s.
[12] Baranova, E.V., Verhoef, T.I., Asselbergs, F.W., de Boer, A. and Maitland-van der Zee, A.H. (2015).
Genotype-guided coumarin dosing: where are we now and where do we need to go next? Expert Opin.
Drug Metab Toxicol
. 11(4), 509-22.
[13] Tongsrisomboon, P. (2009).
Inpatient warfarin monitoring service at Ramathibodi Hospital
.
Thesis for the degree of Master of Science in Pharmacy (Clinical Pharmacy). Mahidol University.
[14] ÿöćÙöĒóì÷Ť
ēøÙĀĆ
üĔÝĒĀŠ
Üðøąđìýĕì÷ǰĔîóøąïøöøćßĎ
ðëĆ
öõŤ
ǰ (2553). “ך
ĂïŠ
ÜßĊĚ
ĔîÖćøĔßš
÷ćêš
ćîÖćøĒ×Ę
ÜêĆ
ü×ĂÜ
đúČ
Ăéßîĉ
éøĆ
ïðøąìćîǰ üĂøŤ
ôćøĉ
î ”.
ĒîüìćÜÖćøøĆ
ÖþćñĎš
ðś
ü÷éš
ü÷÷ćêš
ćîÖćøĒ×Ę
ÜêĆ
ü×ĂÜđúČ
Ăéßîĉ
éøĆ
ïðøąìćî
.
ö ð ì
[15] Ezekowitz, M.D. (2002). Anticoagulation management of valve replacement patients.
J Heart
Valve Dis
. 11(Suppl 1), S56-60.
[16] Yoon, I.K., Lee, K.E., Lee, J.K., Chang, B.C. and Gwak, H.S. (2013). Adequate intensity of warfarin
therapy for Korean patients with mechanical cardiac valves.
J Heart Valve Dis
. 22(1), 102-9.
[17] Wu, L., Chang, Q., Wang, T., Zhang, Z., Lou, Y.. (2015). Clinical observation of postoperative
warfarin anticoagulation in 300 patients undergoing mitral valve replacement with a carbomedics
mechanical valve.
Heart Surg Forum
. 18(2), E063-E066.
[18] Kanaoka, Y., Tanemoto, K., Murakami, T. and Kuroki, K. (2000). Thromboembolic and bleeding
complications in patients treated with oral anticoagulant therapy after mechanical heart valve
prostheses implantation.
Kyobu Geka
. 53(9), 754-8.
